CX3CR1 and early-onset autosomal dominant Alzheimer disease: While those studies focused on the measurement of Aβ accumulation, and microglial proliferation seemed to confirm the beneficial effects of CX3CR1 removal in Alzheimer’s disease mouse models, other studies have demonstrated that this alteration could potentiate the behavioral deficits that characterize this disease, with memory impairment being the most relevant [47].